Biotalys lists on Euronext Brussels

Back

€54.6 million raised – market capitalisation of approx. €232 million

Brussels – 2 July 2021 – Euronext today congratulates the agricultural technology (AgTech) company Biotalys on its IPO on Euronext Brussels (ticker code: BTLS).

Biotalys is an AgTech company focused on addressing food protection challenges with protein-based biocontrol solutions for more sustainable and safer food. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and its headquarters are located in the vibrant biotech cluster in Ghent, Belgium. 

Biotalys was listed through the admission to trading of the 30,020,387 shares making up its equity, including 6,333,333 new shares issued under a Public Offering. 949,999 additional new shares could be issued and admitted to trading upon the possible exercise of the over-allotment option.

The admission and issue price of Biotalys’ shares was set at €7.50 per share. Market capitalisation was €232.3 million on the day of listing and the offering raised €54.6 million altogether (assuming the exercise in full of the over-allotment option).

Biotalys intends to use the proceeds of the transaction to fund the development of its existing pipeline, to fund the continued improvement and optimisation of its AGROBODY Foundry™ platform, to fund its go-to-market strategy and for general corporate purposes.

Patrice Sellès, Chief Executive Officer of Biotalys, said: “Our IPO today represents years of hard work from across our company, from the Biotalys team to our investors and partners. We are proud to be listing on Euronext Brussels and entering this exciting new stage of growth as a public company. We have seen tremendous support and positive feedback for our story from international institutional and local investors alike, who – like us – believe that we can make a lasting difference to a more sustainable and safe way to protect food, reduce food waste and provide healthier and safer choices for all.

Biotalys

Caption: Patrice Sellès, Chief Executive Officer of Biotalys, and his team rang the bell during a ceremony this morning together with Vincent Van Dessel, CEO of Euronext Brussels, to celebrate the Initial Public Offering of the company.

About Biotalys

Biotalys is an Agricultural Technology (AgTech) company focused on addressing food protection challenges with protein-based biocontrol solutions for more sustainable and safer food. Based on its novel AGROBODY™ technology platform, Biotalys aims to develop a strong and diverse pipeline of effective products with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and has since then gained support from renowned Belgian and international investors. The Company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com.

Press Release Footer

About Euronext 
Euronext is the leading European capital market infrastructure, covering the entire capital markets value chain, from listing, trading, clearing, settlement and custody, to solutions for issuers and investors. Euronext runs MTS, one of Europe’s leading electronic fixed income trading markets, and Nord Pool, the European power market. Euronext also provides clearing and settlement services through Euronext Clearing and its Euronext Securities CSDs in Denmark, Italy, Norway, and Portugal. As of December 2024, Euronext’s regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway, and Portugal host over 1,800 listed issuers with around €6 trillion in market capitalisation, a strong blue-chip franchise and the largest global centre for debt and fund listings. With a diverse domestic and international client base, Euronext handles 25% of European lit equity trading. Its products include equities, FX, ETFs, bonds, derivatives, commodities and indices. 
For the latest news, follow us on X (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).

Disclaimer
This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2025, Euronext N.V. - All rights reserved.